LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Test Results of Fingerstick Blood Vary Significantly

By LabMedica International staff writers
Posted on 29 Nov 2015
Image: Blood obtained via fingerstick is commonly used in point-of-care assays (Photo courtesy of The Health).
Image: Blood obtained via fingerstick is commonly used in point-of-care assays (Photo courtesy of The Health).
Blood obtained via fingerstick is commonly used in point-of-care assays, but few studies have assessed variability in parameters obtained from successive drops of fingerstick blood, which may cause problems for clinical decision making and for assessing accuracy of point-of-care tests.

The most accurate way to carry out medial laboratory tests is to draw blood from a vein and send it to a laboratory but sometimes, such as in low-resource settings, results are needed more rapidly, or the health professional is not trained to draw vein-blood, or there is no laboratory. In such settings, there is a higher reliance on fingerstick tests.

Bioengineers at Rice University (Houston, TX, USA) used a hematology analyzer to analyze the hemoglobin concentration, total white blood cell (WBC) count, three-part WBC differential, and platelet count in six successive 20 µL of blood collected from one fingerstick from each of 11 donors. The team used a hemoglobinometer to measure the hemoglobin concentration of 10 drops of fingerstick blood from each of seven donors to check whether the minimum droplet size made a difference and they checked all the results against blood taken from donors' veins. They also followed best practice to ensure accurate results. For example, they wiped away the first droplet to remove traces of disinfectant, and they did not squeeze or "milk" the finger.

The results showed that hemoglobin content, platelet count and white blood cell count varied significantly from drop to drop. The average percent coefficient of variation (CV) for successive drops of fingerstick blood was higher by up to 3.4 times for hemoglobin, 5.7 times for WBC count, three times for lymphocyte count, 7.7 times for granulocyte count, and four times for platelets than in venous controls measured using a hematology analyzer. The average percent CV for fingerstick blood was up to five times higher for hemoglobin than venous blood measured using a point-of-care hemoglobinometer. The investigators found that averaging the results of six to nine successive droplet tests produced results on a par with the venous blood tests.

Meaghan M. Bond, a doctoral student and first author of the study, said, “In some donors, the hemoglobin concentration changed by more than 2 g/dL in the span of two successive drops of blood. Our results show that people need to take care to administer fingerstick tests in a way that produces accurate results because accuracy in these tests is increasingly important for diagnosing conditions like anemia, infections and sickle-cell anemia, malaria, HIV and other diseases.” The study was published on November 18, 2015, in the American Journal of Clinical Pathology.

Related Links:

Rice University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automatic CLIA Analyzer
Shine i9000
Automated MALDI-TOF MS System
EXS 3000

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more